Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders
Tiziana Bisogno, Vincenzo Di Marzo
CNS & Neurological Disorders - Drug Targets (2010) Vol. 9, Iss. 5, pp. 564-573
Closed Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 414
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
Pál Pacher, Raphael Mechoulam
Progress in Lipid Research (2011) Vol. 50, Iss. 2, pp. 193-211
Open Access | Times Cited: 402
Modulating the endocannabinoid system in human health and disease – successes and failures
Pál Pacher, George Kunos
FEBS Journal (2013) Vol. 280, Iss. 9, pp. 1918-1943
Open Access | Times Cited: 369
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Fabio Arturo Iannotti, Vincenzo Di Marzo, Stefania Petrosino
Progress in Lipid Research (2016) Vol. 62, pp. 107-128
Closed Access | Times Cited: 324
Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's Disease
Rongqing Chen, Jian Zhang, Yan Wu, et al.
Cell Reports (2012) Vol. 2, Iss. 5, pp. 1329-1339
Open Access | Times Cited: 239
Microglia
Eduardo E. Benarroch
Neurology (2013) Vol. 81, Iss. 12, pp. 1079-1088
Closed Access | Times Cited: 205
Endocannabinoids drive the acquisition of an alternative phenotype in microglia
Míriam Mecha, Ana Feliú, Francisco Carrillo‐Salinas, et al.
Brain Behavior and Immunity (2015) Vol. 49, pp. 233-245
Closed Access | Times Cited: 195
Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling
Oihane Abiega, Sol Beccari, Irune Díaz‐Aparicio, et al.
PLoS Biology (2016) Vol. 14, Iss. 5, pp. e1002466-e1002466
Open Access | Times Cited: 178
Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity
Lisa K. Brents, Emily E. Reichard, Sarah M. Zimmerman, et al.
PLoS ONE (2011) Vol. 6, Iss. 7, pp. e21917-e21917
Open Access | Times Cited: 205
A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer's Disease
Justin R. Piro, Daniel I. Benjamin, James M. Duerr, et al.
Cell Reports (2012) Vol. 1, Iss. 6, pp. 617-623
Open Access | Times Cited: 196
Neurotransmitter receptors on microglia
Huan Liu, Rehana K. Leak, Xiaoming Hu
Stroke and Vascular Neurology (2016) Vol. 1, Iss. 2, pp. 52-58
Open Access | Times Cited: 158
Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity
Lisa K. Brents, Anna Gallus‐Zawada, Anna Radomińska‐Pandya, et al.
Biochemical Pharmacology (2012) Vol. 83, Iss. 7, pp. 952-961
Open Access | Times Cited: 143
The endocannabinoid system in normal and pathological brain ageing
András Bilkei‐Gorzó
Philosophical Transactions of the Royal Society B Biological Sciences (2012) Vol. 367, Iss. 1607, pp. 3326-3341
Open Access | Times Cited: 128
Synaptic and Cognitive Improvements by Inhibition of 2-AG Metabolism Are through Upregulation of MicroRNA-188-3p in a Mouse Model of Alzheimer's Disease
Jian Zhang, Mei Hu, Zhao‐Qian Teng, et al.
Journal of Neuroscience (2014) Vol. 34, Iss. 45, pp. 14919-14933
Open Access | Times Cited: 121
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
Daniel J. Hermanson, Nolan D. Hartley, Joyonna Gamble‐George, et al.
Nature Neuroscience (2013) Vol. 16, Iss. 9, pp. 1291-1298
Open Access | Times Cited: 116
Endocannabinoids in Synaptic Plasticity and Neuroprotection
Jianyi Xu, Chu Chen
The Neuroscientist (2014) Vol. 21, Iss. 2, pp. 152-168
Open Access | Times Cited: 115
Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review
Ruwini Cooray, Veer Bala Gupta, Cenk Suphioglu
Molecular Neurobiology (2020) Vol. 57, Iss. 11, pp. 4878-4890
Open Access | Times Cited: 111
The Potential Therapeutic Effects of THC on Alzheimer's Disease
Chuanhai Cao, Yaqiong Li, Hui Liu, et al.
Journal of Alzheimer s Disease (2014) Vol. 42, Iss. 3, pp. 973-984
Closed Access | Times Cited: 108
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 106
Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure
Laura Cutando, Arnau Busquets‐Garcia, Emma Puighermanal, et al.
Journal of Clinical Investigation (2013) Vol. 123, Iss. 7, pp. 2816-2831
Open Access | Times Cited: 105
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia
Gemma Navarro, Dasiel O. Borroto‐Escuela, Edgar Angelats, et al.
Brain Behavior and Immunity (2017) Vol. 67, pp. 139-151
Closed Access | Times Cited: 104
How to reprogram microglia toward beneficial functions
Marta Fumagalli, Marta Lombardi, Pierre Gressèns, et al.
Glia (2018) Vol. 66, Iss. 12, pp. 2531-2549
Open Access | Times Cited: 94
Marijuana, the Endocannabinoid System and the Female Reproductive System.
Lisa K. Brents
PubMed (2016) Vol. 89, Iss. 2, pp. 175-91
Closed Access | Times Cited: 88
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging
Önder Albayram, Judith Alferink, Julika Pitsch, et al.
Proceedings of the National Academy of Sciences (2011) Vol. 108, Iss. 27, pp. 11256-11261
Open Access | Times Cited: 112
Functional characterization of putative cholesterol binding sequence (CRAC) in human type‐1 cannabinoid receptor
Sergio Oddi, Enrico Dainese, Filomena Fezza, et al.
Journal of Neurochemistry (2011) Vol. 116, Iss. 5, pp. 858-865
Closed Access | Times Cited: 100
Page 1 - Next Page

Scroll to top